The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126709741 12670974 1 I 2012 20160329 20160822 20160822 PER US-JAZZ-2016-US-006040 JAZZ 0.00 F Y 0.00000 20160822 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126709741 12670974 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID U 21196 2.25 G ORAL SOLUTION
126709741 12670974 2 SS XYREM SODIUM OXYBATE 1 Oral DOSE ADJUSTMENTS U 21196 ORAL SOLUTION
126709741 12670974 3 SS XYREM SODIUM OXYBATE 1 Oral 4 G, FIRST DOSE U 21196 4 G ORAL SOLUTION
126709741 12670974 4 SS XYREM SODIUM OXYBATE 1 Oral 3 G, SECOND DOSE U 21196 3 G ORAL SOLUTION
126709741 12670974 5 SS XANAX ALPRAZOLAM 1 UNK Y U 0 TABLET
126709741 12670974 6 C Propranolol er 2 U 0 CAPSULE
126709741 12670974 7 C SUMATRIPTAN SUCCINATE. SUMATRIPTAN SUCCINATE 1 U 0 TABLET
126709741 12670974 8 C ADDERALL AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 UNK U 0 TABLET
126709741 12670974 9 C NEURONTIN GABAPENTIN 1 UNK U 0 CAPSULE
126709741 12670974 10 C DEPAKOTE DIVALPROEX SODIUM 1 UNK U 0 TABLET
126709741 12670974 11 C NUVIGIL ARMODAFINIL 1 UNK U 0 TABLET
126709741 12670974 12 C SEROQUEL QUETIAPINE FUMARATE 1 UNK U 0 TABLET
126709741 12670974 13 C FOCALIN XR DEXMETHYLPHENIDATE HYDROCHLORIDE 1 UNK U 0 CAPSULE
126709741 12670974 14 C ESZOPICLONE. ESZOPICLONE 1 U 0 TABLET
126709741 12670974 15 C Gildess ETHINYL ESTRADIOLNORETHINDRONE ACETATE 1 1 MG-20 MCG U 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126709741 12670974 1 Narcolepsy
126709741 12670974 2 Cataplexy
126709741 12670974 5 Product used for unknown indication
126709741 12670974 6 Product used for unknown indication
126709741 12670974 7 Product used for unknown indication
126709741 12670974 8 Product used for unknown indication
126709741 12670974 9 Product used for unknown indication
126709741 12670974 10 Product used for unknown indication
126709741 12670974 11 Product used for unknown indication
126709741 12670974 12 Product used for unknown indication
126709741 12670974 13 Product used for unknown indication
126709741 12670974 14 Product used for unknown indication
126709741 12670974 15 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126709741 12670974 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126709741 12670974 Intentional product misuse
126709741 12670974 Migraine
126709741 12670974 Suicidal ideation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126709741 12670974 1 201305 201306 0
126709741 12670974 3 201502 2015 0
126709741 12670974 4 201502 2015 0
126709741 12670974 5 2012 2015 0
126709741 12670974 8 20141009 0
126709741 12670974 9 20140415 201405 0
126709741 12670974 10 20130201 20140415 0
126709741 12670974 11 20130201 0
126709741 12670974 12 20130101 20140415 0
126709741 12670974 13 20100501 20140415 0